{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06339138",
            "orgStudyIdInfo": {
                "id": "17-010944"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2024-00971",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "17-010944",
                    "type": "OTHER",
                    "domain": "Mayo Clinic in Rochester"
                }
            ],
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study",
            "officialTitle": "Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing in Blood and Urine",
            "therapeuticArea": [
                "Nephrology and Renal Diseases",
                "Oncology and Hematology"
            ],
            "study": "identification-of-novel-high-quality-methylated-dna-markers-in-renal-tumors-whole-methylome-discovery-tissue-validation-and-feasibility-testing-in-blood-and-urine-the-inquire-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2018-02-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-01-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-01-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-25",
            "studyFirstSubmitQcDate": "2024-03-25",
            "studyFirstPostDateStruct": {
                "date": "2024-04-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is being done to collect blood, tissue and urine samples to identify a novel high quality methylated DNA marker in patients with renal tumors.",
            "detailedDescription": "PRIMARY OBJECTIVES:\n\nI. In tissue, to discover and validate DNA methylation markers (MDMs) for detection of malignant renal and urothelial tumors.\n\nII. In blood, to assess the accuracy of candidate MDMs from above for detection of malignant renal and urothelial tumors.\n\nOUTLINE: This is an observational study.\n\nParticipants may undergo blood, urine, and tissue sample collection on study. Participants' medical records are also reviewed."
        },
        "conditionsModule": {
            "conditions": [
                "Chromophobe Renal Cell Carcinoma",
                "Clear Cell Papillary Renal Tumor",
                "Clear Cell Renal Cell Carcinoma",
                "Kidney Oncocytoma",
                "Papillary Renal Cell Carcinoma",
                "Urothelial Carcinoma"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "designInfo": {
                "observationalModel": "CASE_CONTROL",
                "timePerspective": "CROSS_SECTIONAL"
            },
            "enrollmentInfo": {
                "count": 874,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Observational",
                    "description": "Participants may undergo blood, urine, and tissue sample collection on study. Participants' medical records are also reviewed.",
                    "interventionNames": [
                        "Other: Non-Interventional Study"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Non-Interventional Study",
                    "description": "Non-interventional study",
                    "armGroupLabels": [
                        "Observational"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Identify novel methylated DNA markers in tissue for malignant renal and urothelial tumors",
                    "description": "Assessed by the number of markers identified using unbiased whole methylome sequencing (RRBS). Top candidates will be validated in independent tissue. Potential markers will have relatively low background and a false discovery rate 20%.",
                    "timeFrame": "Baseline (at enrollment)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* CASE TISSUE:\n\n  * Patient has a histological diagnosis of primary clear cell RCC, papillary cell RCC, clear cell papillary RCC, chromophobe RCC, oncocytoma, or urothelial cell carcinoma\n  * Age \\>= 18 years\n* CASE BLOODS AND URINE:\n\n  * Patient has a histological diagnosis of primary clear cell RCC, papillary cell RCC, chromophobe RCC, oncocytoma, or urothelial cell carcinoma\n  * Age \\>= 18 years\n* HEALTHY CONTROL BLOODS AND URINE:\n\n  * Patients has undergone negative hematuria workups (defined as negative abdominal imaging and negative cystoscopy\n  * Age \\>= 18 years\n\nExclusion Criteria:\n\n* CASE TISSUE:\n\n  * Patient has von Hippel-Lindau disease (VHL), Hereditary leiomyomatosis and renal cell cancer (HLRCC), Hereditary papillary renal carcinoma (HPRC), or Birt-Hogg-Dube syndrome (BHD)\n  * The current target pathology is a recurrence\n  * Patient has undergone any prior radiation therapy to target lesion prior to surgery\n  * Patient has received chemotherapy class drugs in the 5 years prior to surgery\n  * Patient has had any transplants prior to surgery\n  * Patient has confirmation of Lynch Syndrome, is presumed to have Lynch Syndrome, or has familial cancer syndrome X\n  * Patient has Nephritis (Glomerulus or Interstitial), Poly Cystic Kidney Disease, Glomerulonephropathies or Acquired Renal Kidney Disease\n* RENAL CONTROL TISSUE:\n\n  * Patient has von Hippel-Lindau disease (VHL), Hereditary leiomyomatosis and renal cell cancer (HLRCC), Hereditary papillary renal carcinoma (HPRC), or Birt-Hogg-Dube syndrome (BHD).\n  * Patient has inflammation, atypia, or hyperplasia of the parenchyma\n  * Patient has a current or past history of renal cancer.\n  * Patient has undergone any prior radiation therapy to target lesion prior to surgery\n  * Patient has received chemotherapy class drugs in the 5 years prior to surgery\n  * Patient has had any transplants prior to surgery\n  * Patient has confirmation of Lynch Syndrome, is presumed to have Lynch Syndrome, or has familial cancer syndrome X\n  * Patient has Nephritis (Glomerulus or Interstitial), Poly Cystic Kidney Disease, Glomerulonephropathies or Acquired Renal Kidney Disease\n* UROTHELIEAL CONTROL TISSUE:\n\n  * Patient has von Hippel-Lindau disease (VHL), Hereditary leiomyomatosis and renal cell cancer (HLRCC), Hereditary papillary renal carcinoma (HPRC), or Birt-Hogg-Dub\u00e9 syndrome (BHD)\n  * Patient has inflammation, atypia, or hyperplasia of the urothelium\n  * Patient has a current or past history of urothelial cancer\n  * Patient has undergone any prior radiation therapy to target lesion prior to surgery\n  * Patient has received chemotherapy class drugs in the 5 years prior to surgery\n  * Patient has had any transplants prior to surgery\n  * Patient has confirmed or presumed lynch\n* CASE BLOODS AND URINE:\n\n  * Patient has known primary cancer outside of the kidney within the last 5 years prior to plasma and urine collection (not including basal cell or squamous cell skin cancers)\n  * Patient has had surgery to completely or partially remove current target pathology\n  * Patient has undergone any prior radiation therapy to target lesion prior to plasma and urine collection\n  * Patient has received chemotherapy class drugs in the 5 years prior to plasma and urine collection\n  * Patient has had any transplants prior to plasma and urine collection\n  * Patient has confirmed or presumed lynch\n  * Patient has von Hippel-Lindau disease (VHL), Hereditary leiomyomatosis and renal cell cancer (HLRCC), Hereditary papillary renal carcinoma (HPRC), or Birt-Hogg-Dub\u00e9 syndrome (BHD)\n* HEALTHY CONTROL BLOODS AND URINE:\n\n  * Patient has known primary cancer outside of the urothelium within the last 5 years prior to plasma and urine collection (not including basal cell or squamous cell skin cancers)\n  * Current target pathology is a recurrence\n  * Patient has undergone prior radiation therapy in the 5 years prior to plasma and urine collection\n  * Patient has received chemotherapy class drugs in the 5 years prior to plasma and urine collection\n  * Patient has had any transplants prior to plasma and urine collection\n  * Patient has von Hippel-Lindau disease (VHL), Hereditary leiomyomatosis and renal cell cancer (HLRCC), Hereditary papillary renal carcinoma (HPRC), or Birt-Hogg-Dube syndrome (BHD)\n  * Patient has confirmed or presumed lynch\n  * Gross urinary incontinence\n  * Patient has undergone cystectomy",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Patients with a histological diagnosis of primary clear cell RCC, papillary cell RCC, clear cell papillary RCC, chromophobe RCC, oncocytoma, urothelial cell carcinoma, or healthy participants who have undergone negative hematuria workups",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "John C. Cheville, M.D.",
                    "affiliation": "Mayo Clinic in Rochester",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Trials Referral Office",
                            "role": "CONTACT",
                            "phone": "855-776-0015",
                            "email": "mayocliniccancerstudies@mayo.edu"
                        },
                        {
                            "name": "John C. Cheville, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "John B. Kisiel, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000002292",
                    "term": "Carcinoma, Renal Cell"
                },
                {
                    "id": "D000007680",
                    "term": "Kidney Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10703",
                    "name": "Kidney Neoplasms",
                    "asFound": "Renal Tumors",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5551",
                    "name": "Carcinoma, Transitional Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M5548",
                    "name": "Carcinoma, Renal Cell",
                    "asFound": "Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20395",
                    "name": "Adenoma, Oxyphilic",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5693",
                    "name": "Transitional Cell Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T4906",
                    "name": "Renal Cell Carcinoma",
                    "asFound": "Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1341",
                    "name": "Clear Cell Renal Cell Carcinoma",
                    "asFound": "Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4400",
                    "name": "Papillary Renal Cell Carcinoma",
                    "asFound": "Papillary Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1193",
                    "name": "Chromophil Renal Cell Carcinoma",
                    "asFound": "Papillary Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1194",
                    "name": "Chromophobe Renal Cell Carcinoma",
                    "asFound": "Chromophobe Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4918",
                    "name": "Renal Oncocytoma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}